CRP and systemic sclerosis: It has been previously demonstrated that SSc patients have increased levels of fecal calprotectin, which strongly correlate with the presence of small intestinal bacterial overgrowth (SIBO) [15] and other markers of systemic inflammation, such as C-reactive protein (CRP) [16].